Purpose: To measure indicators of timeliness and continuity of treatments on patients with schizophrenic disorder in ‘real-life’ practice, and to validate them through their relationship with relapse occurrences. Methods: The target population was from four Italian regions overall covering 22 million beneficiaries of the NHS (37% of the entire Italian population). The cohort included 12,054 patients newly taken into care for schizophrenic disorder between January 2015 and June 2016. The self-controlled case series (SCCS) design was used to estimate the incidence rate ratio of relapse occurrences according to mental healthcare coverage. Results: Poor timeliness (82% and 33% of cohort members had not yet started treatment with psychosocial interventions and antipsychotic drug therapy within the first year after they were taken into care) and continuity (27% and 23% of patients were persistent with psychosocial interventions, and antipsychotic drug therapy within the first 2 years after starting the specific treatment) were observed. According to SCCS design, 4794 relapses occurred during 9430 PY (with incidence rate of 50.8 every 100 PY). Compared with periods not covered by mental healthcare, those covered by psychosocial intervention alone, antipsychotic drugs alone and by psychosocial intervention and antipsychotic drugs together were, respectively, associated with relapse rate reductions of 28% (95% CI 4–46%), 24% (17–30%) and 44% (32–53%). Conclusion: Healthcare administrative data may contribute to monitor and to assess the effectiveness of a mental health system. Persistent use of both psychosocial intervention and antipsychotic drugs reduces risk of severe relapse.

Corrao, G., Barbato, A., D'Avanzo, B., Di Fiandra, T., Ferrara, L., Gaddini, A., et al. (2022). Does the mental health system provide effective coverage to people with schizophrenic disorder? A self-controlled case series study in Italy. SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY, 57(4 (April 2022)), 519-529 [10.1007/s00127-021-02114-9].

Does the mental health system provide effective coverage to people with schizophrenic disorder? A self-controlled case series study in Italy

Corrao, G
Primo
;
Monzio Compagnoni, M
;
Lora, A
Ultimo
2022

Abstract

Purpose: To measure indicators of timeliness and continuity of treatments on patients with schizophrenic disorder in ‘real-life’ practice, and to validate them through their relationship with relapse occurrences. Methods: The target population was from four Italian regions overall covering 22 million beneficiaries of the NHS (37% of the entire Italian population). The cohort included 12,054 patients newly taken into care for schizophrenic disorder between January 2015 and June 2016. The self-controlled case series (SCCS) design was used to estimate the incidence rate ratio of relapse occurrences according to mental healthcare coverage. Results: Poor timeliness (82% and 33% of cohort members had not yet started treatment with psychosocial interventions and antipsychotic drug therapy within the first year after they were taken into care) and continuity (27% and 23% of patients were persistent with psychosocial interventions, and antipsychotic drug therapy within the first 2 years after starting the specific treatment) were observed. According to SCCS design, 4794 relapses occurred during 9430 PY (with incidence rate of 50.8 every 100 PY). Compared with periods not covered by mental healthcare, those covered by psychosocial intervention alone, antipsychotic drugs alone and by psychosocial intervention and antipsychotic drugs together were, respectively, associated with relapse rate reductions of 28% (95% CI 4–46%), 24% (17–30%) and 44% (32–53%). Conclusion: Healthcare administrative data may contribute to monitor and to assess the effectiveness of a mental health system. Persistent use of both psychosocial intervention and antipsychotic drugs reduces risk of severe relapse.
Articolo in rivista - Articolo scientifico
Effective coverage; Healthcare utilization database; Mental healthcare; Real-world; Schizophrenic disorder; Self-controlled case series;
English
16-giu-2021
2022
57
4 (April 2022)
519
529
open
Corrao, G., Barbato, A., D'Avanzo, B., Di Fiandra, T., Ferrara, L., Gaddini, A., et al. (2022). Does the mental health system provide effective coverage to people with schizophrenic disorder? A self-controlled case series study in Italy. SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY, 57(4 (April 2022)), 519-529 [10.1007/s00127-021-02114-9].
File in questo prodotto:
File Dimensione Formato  
Corrao2021_Article_DoesTheMentalHealthSystemProvi.pdf

accesso aperto

Descrizione: Articolo principale
Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Licenza: Tutti i diritti riservati
Dimensione 1.02 MB
Formato Adobe PDF
1.02 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/316814
Citazioni
  • Scopus 9
  • ???jsp.display-item.citation.isi??? 9
Social impact